TEMPTON Personaldienstleistungen GmbH

  • WKN: A2YPE8
  • ISIN: NO0010861792
  • Land: Deutschland

Nachricht vom 25.10.2021 | 17:15

TEMPTON Personaldienstleistungen GmbH: Full redemption of bonds

TEMPTON Personaldienstleistungen GmbH / Key word(s): Bond
TEMPTON Personaldienstleistungen GmbH: Full redemption of bonds

25-Oct-2021 / 17:15 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


TEMPTON Personaldienstleistungen GmbH - Full redemption of bonds

NOT FOR PUBLICATION OR DISTRIBUTION IN OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER COUNTRY IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Essen, 25 October 2021, 16:15 hours - Reference is made to the stock exchange announcements published by TEMPTON Personaldienstleistungen GmbH ("TEMPTON") on 13 October 2021 and on 20 October 2021 regarding a contemplated bond issue to refinance its existing bond (WKN: A2YPE8 / ISIN: NO0010861792) (the "Bonds").

TEMPTON hereby announces that it has successfully placed a new 5-year EUR 25 million senior secured bond issue. The proceeds from the bond issue will be used to refinance the early redemption of the Bonds, finance acquisitions as well as for general corporate and working capital purposes and the costs associated with the bond issue Issuance of the new bonds. The release of the proceeds is subject to fulfilment of certain conditions precedent.

Pareto Securities AS, Frankfurt Branch is acting as Manager of the transaction.

The Bonds are expected to be called for payment shortly, subject to certain conditions.

*** End of ad hoc announcement ***

For further information please contact:

For TEMPTON Personaldienstleistungen GmbH:
Frau Christina Decker
Head of Marketing
TEMPTON Personaldienstleistungen GmbH
Schürmannstraße 24
45136 Essen
Telefon: +49 201 89479-48
Mail: Christina.Decker@Tempton.de

TEMPTON Investor Relations: https://www.tempton.de/ueber-tempton/investor-relations/

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to the ABM Rules.

This stock exchange announcement was published by Frank Seipenbusch, CFO, on 25 October 2021 at 16:15 CEST.


25-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Neufassung der Dividendenpolitik der Allianz SE

02. Dezember 2021, 20:33

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021